1st Quarter - Report — EPILEPSY FOUNDATION for EPILEPSY FOUNDATION (2014)

Firm

EPILEPSY FOUNDATION

Client

EPILEPSY FOUNDATION

Income

—

Expenses

$60,000

Expense method

B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health care reform legislation; Medicare and Medicaid related issues and prescription drug policy; Medicare policy reforms Prescription drug access issues; support for epilepsy awareness programs

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
ANGELA OSTROM	—

Contacted: Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); White House Office; SENATE

Civil Rights/Civil Liberties CIV

Support for United Nations disability rights treaty (CRPD)

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
ANGELA OSTROM	—

Contacted: Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); White House Office; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Budget/Appropriations BUD

Labor, HHS, Education and Related Agencies appropriations for NIH, CDC, HRSA Funding for Lifespan Respite Care Act Funding for epilepsy research and programs Prescription drug access issue appropriations

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
ANGELA OSTROM	—

Contacted: Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); SENATE; Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); White House Office; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.